Filing Flows

Filing Flows › Zimmer Biomet Holdings (ZBH) › Recalls, complaints & regulation

Zimmer Biomet Holdings (ZBH): recalls, EPA violations and clinical trials

Zimmer Biomet Holdings (ZBH) beyond its filings: 0 recalls in the last 12 months (1 in five years, 0 Class I); 4 EPA-regulated facilities in violation, $4K in penalties over five years; 64 active clinical trials.

Latest recalls

EPA facilities in violation

Facility (as registered)CityStatusPenalties
ZIMMER TRABECULAR METAL TECHNOLOGYParsippany, NJViolation Identified$4K
ZIMMER, INC.Warsaw, INSignificant Violation—
ZIMMER CONST CBPoulsbo, WASignificant Violation—
ZIMMER BIOMET INCORPORATED PLANT 3Warsaw, INViolation Identified—

Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.

Zimmer Biomet Holdings' latest quarter

Zimmer Biomet Holdings, Q3 2026: revenue $2.1B (+3% year over year), operating margin 14.9%, net earnings $193M, operating cash flow $560M. The chart follows the revenue to costs, profit and cash.

Questions

Has Zimmer Biomet Holdings had any recalls?

1 recall on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.

Has Zimmer Biomet Holdings been fined by the EPA?

The 29 EPA-regulated facilities on file under its name drew $4K in penalties over five years; 4 are in violation now.

How many clinical trials does Zimmer Biomet Holdings have?

64 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.